Mobile health for type 2 diabetes
- Conditions
- Type 2 diabetesNutritional, Metabolic, EndocrineType 2 diabetes mellitus
- Registration Number
- ISRCTN14335124
- Lead Sponsor
- iverpool John Moores University
- Brief Summary
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34836904/ (added 29/11/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 125
1. Clinical Diagnosis of T2D within the previous 5–24 months
2. Aged 40 - 75 years
3. Treating diabetes with only Metformin or lifestyle modifications (diet and exercise)
4. For those prescribed Metformin: Stable dose for 3-months or more
1. HbA1c >10% (>86mmol/mol)
2. Blood pressure >160/100 mmHg
3. Prescription of oral antidiabetic drug other than Metformin
4. Prescription of Insulin
5. Unstable angina
6. Myocardial infarction within the previous 3 months
7. Transient ischemic attack (TIA) in the previous 6 months
8. Heart failure >= class 2
9. Inability to increase level of activity
10. Pregnancy or planning to become pregnant
11. <6 months postpartum or stopped breastfeeding <1 month before recruitment
12. Not owning a smartphone/ or having no data plan or access to WiFi
13. Currently meeting the recommended exercise guidelines (150 min of moderate intensity exercise per week)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility outcomes:<br>1. The number of adults with newly diagnosed T2D that are eligible to participate<br>2. The proportion of these who would be willing to take part in this trial (i.e. recruitment rate), and their characteristics <br>3. The number of participants retained at 12-months (i.e. participant drop-out)
- Secondary Outcome Measures
Name Time Method